Literature DB >> 9551950

Identification of the mouse IgG3 receptor: implications for antibody effector function at the interface between innate and adaptive immunity.

A L Gavin1, N Barnes, H M Dijstelbloem, P M Hogarth.   

Abstract

Mouse IgG3 appears early in immune responses independently of T cell help and, as such, is an early effector molecule of the immune system. Yet, a specific IgG3 cellular receptor remains undefined. In transfection experiments, mouse Fc gammaRI was clearly able to bind immune complexes of IgG3, whereas mouse Fc gammaRII could not. Furthermore, macrophages from mice expressing Fc gammaRII and Fc gammaRIII but lacking Fc gammaRI were unable to phagocytose IgG3 immune complexes, thus identifying mouse Fc gammaRI as the sole receptor for IgG3 immune complexes. Competition studies demonstrated that monomeric mouse IgG3 could inhibit IgG2a binding to mouse Fc gammaRI with an ID50 approximately 10(-7) M (fivefold lower than IgG2a). The identification of mouse Fc gammaRI as the IgG3 receptor establishes Fc gammaRI as a participant in events at the interface between innate and adaptive immunity, implying a greater role for this receptor in the development of normal and pathologic immune responses than previously recognized.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9551950

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

1.  Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-gammaRI receptors.

Authors:  P Vukovic; P M Hogarth; N Barnes; D C Kaslow; M F Good
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

Review 2.  Isotype-dependent pathogenicity of autoantibodies: analysis in experimental autoimmune hemolytic anemia.

Authors:  S Izui; L Fossati-Jimack; S A da Silveira; T Moll
Journal:  Springer Semin Immunopathol       Date:  2001-12

3.  Efficient IgG-mediated suppression of primary antibody responses in Fcgamma receptor-deficient mice.

Authors:  M C Karlsson; S Wernersson; T Diaz de Ståhl; S Gustavsson; B Heyman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

4.  Differential requirement of lipid rafts for FcγRIIA mediated effector activities.

Authors:  Joshua A Vieth; Moo-Kyung Kim; Xiao Qing Pan; Alan D Schreiber; Randall G Worth
Journal:  Cell Immunol       Date:  2010-08-01       Impact factor: 4.868

5.  Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection.

Authors:  David O Beenhouwer; Esther M Yoo; Chun-Wei Lai; Miguel A Rocha; Sherie L Morrison
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

6.  Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles.

Authors:  Daniel L Sprague; Bennett D Elzey; Scott A Crist; Thomas J Waldschmidt; Robert J Jensen; Timothy L Ratliff
Journal:  Blood       Date:  2008-01-15       Impact factor: 22.113

7.  Carbohydrate-monophosphoryl lipid a conjugates are fully synthetic self-adjuvanting cancer vaccines eliciting robust immune responses in the mouse.

Authors:  Qianli Wang; Zhifang Zhou; Shouchu Tang; Zhongwu Guo
Journal:  ACS Chem Biol       Date:  2011-11-01       Impact factor: 5.100

8.  Essential role for humoral immunity during Ehrlichia infection in immunocompetent mice.

Authors:  Eric Yager; Constantine Bitsaktsis; Bisweswar Nandi; Jere W McBride; Gary Winslow
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

9.  Suppressive and additive effects in protection mediated by combinations of monoclonal antibodies specific for merozoite surface protein 1 of Plasmodium yoelii.

Authors:  Irosoki Eslava; Gilberto Payares; Beatriz M Pernia; Anthony A Holder; Lilian M Spencer
Journal:  Malar J       Date:  2010-02-10       Impact factor: 2.979

10.  Synthesis and immunological evaluation of a MUC1 glycopeptide incorporated into l-rhamnose displaying liposomes.

Authors:  Sourav Sarkar; Alex C D Salyer; Katherine A Wall; Steven J Sucheck
Journal:  Bioconjug Chem       Date:  2013-03-08       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.